Title: Solifenacin Treatment for Neurogenic Detrusor Overactivity: Patient-Reported Outcomes (pros) from the Randomised Clinical Trial Sonic
Authors: De Ridder, Dirk
Amarenco, G
Finazzi, Agro E
Angulo, J
Kurenkov, A
Wright, M
Fagertun, H
Compion, G #
Issue Date: Oct-2012
Publisher: Allen R. Liss
Conference: Annual Meeting of the International Continence Society edition:42 location:Beijing, China date:15-19 October 2012
Abstract: Hypothesis / aims of study
Many patients with spinal cord injury (SCI) or multiple sclerosis (MS) develop neurogenic detrusor overactivity (NDO) (1,2). SONIC investigated the efficacy and safety of fixed doses of solifenacin as a treatment for NDO. Here we present preliminary results for patient-reported outcomes (PROs).
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Screening, Diagnostics and Biomarkers (-)
# (joint) last author

Files in This Item:

There are no files associated with this item.


All items in Lirias are protected by copyright, with all rights reserved.